CTI Molecular Imaging reported second-quarter net revenue of $106.3 million, up 30% compared with the $81.9 million turned in during the second quarter last year. For the period (end-March 31), the Knoxville, TN-based vendor had net income of $5.8 million, compared with net income of $4.8 million a year ago.
On a consolidated basis, CTI sold 45 scanners and booked orders for an additional 38 units. Of these, the vendor's direct distribution arm CTI Solutions shipped nine scanners and booked orders for an additional 15 systems.
Although scanner shipments from CTI Solutions were below the company's plan in the second quarter, the segment did experience strong growth in sales of FDG, CTI said. The number of FDG doses increased 60% compared with the previous year's quarter, and 16% compared with the first quarter, which was partially offset by a 3% sequential decline in average price. CTI also opened two new molecular biomarker manufacturing and distribution centers in Birmingham, AL, and Baltimore.
By AuntMinnie.com staff writersMay 5, 2004
Related Reading
CTI and Siemens retool PET alliance, May 5, 2004
PETNet inks deal with GlaxoSmithKline, March 2, 2004
Siemens, Trident ink deal, March 25, 2004
PETNet renews Merck agreement, February 12, 2004
CTI continues growth in Q1, February 3, 2004
Copyright © 2004 AuntMinnie.com
